Evaluation of the efficiency and safety of combined treatment with impaza and nitrates in CHD patients with erectile dysfunction.
The safety of combined administration of ultralow doses of antigens to endothelial NO synthase (impaza) and nitrates for the treatment of erectile dysfunction in CHD patients was evaluated in an open non-comparative clinical trial. The efficiency and safety of impaza and the possibility of its administration to patients receiving nitrates were demonstrated.
Zhavbert
E S
ES
Saratov Research Institute of Cardiology, Federal Agency for Health Care and Social Development.
Kachanova
M V
MV
Tarasov
S A
SA
Dugina
Yu L
YL
Sergeeva
S A
SA
Dovgalevskii
P Ya
PY
Epshtein
O I
OI
D000906:Antibodies / Q000009:adverse effects / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications*; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009566:Nitrates / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use
D000906:Antibodies; C534505:IMPAZA; D009566:Nitrates; D014665:Vasodilator Agents